TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi. Issue 5 (20th May 2022)

• Record Type: Journal Article
• Authors: Tomeny, Ewan M; Nightingale, Rebecca; Chinoko, Beatrice; Nikolaidis, Georgios F; Madan, Jason J; Worrall, Eve; Ngwira, Lucky Gift; Banda, Ndaziona Peter; Lönnroth, Knut; Evans, Denise; Chakaya, Jeremiah; Rylance, Jamie; Mortimer, Kevin; Squire, S. Bertel; Meghji, Jamilah
• Is Part Of: BMJ global health. Volume 7:Issue 5(2022)
• Publication Date: 2022-05-20
• Subjects: tuberculosis -- health economics -- health policy -- cohort study -- indices of health and disease and standardisation of rates; World health -- Periodicals; 362.105
• DOI: 10.1136/bmjgh-2021-007643
• Languages: English
• ISSNs: 2059-7908

Abstract

Abstract : Introduction: Despite growing evidence of the long-term impact of tuberculosis (TB) on quality of life, Global Burden of Disease (GBD) estimates of TB-related disability-adjusted life years (DALYs) do not include post-TB morbidity, and evaluations of TB interventions typically assume treated patients return to pre-TB health. Using primary data, we estimate years of life lost due to disability (YLDs), years of life lost due to premature mortality (YLL) and DALYs associated with post-TB cardiorespiratory morbidity in a low-income country. Methods: Adults aged ≥15 years who had successfully completed treatment for drug-sensitive pulmonary TB in Blantyre, Malawi (February 2016–April 2017) were followed-up for 3 years with 6-monthly and 12-monthly study visits. In this secondary analysis, St George's Respiratory Questionnaire data were used to match patients to GBD cardiorespiratory health states and corresponding disability weights (DWs) at each visit. YLDs were calculated for the study period and estimated for remaining lifespan using Malawian life table life expectancies. YLL were estimated using study mortality data and aspirational life expectancies, and post-TB DALYs derived. Data were disaggregated by HIV status and gender. Results: At treatment completion, 222/403 (55.1%) participants met criteria for a cardiorespiratory DW, decreasing to 15.6% after 3 years, at which point two-thirds of the disability burden was experienced by women. Over 90% of projected lifetime-YLD were concentrated within the most severely affected 20% of survivors. Mean DWs in the 3 years post-treatment were 0.041 (HIV-) and 0.025 (HIV+), and beyond 3 years estimated as 0.025 (HIV-) and 0.010 (HIV+), compared with GBD DWs of 0.408 (HIV+) and 0.333 (HIV-) during active disease. Our results imply that the majority of TB-related morbidity occurs post-treatment . Conclusion: TB-related DALYs are greatly underestimated by overlooking post-TB disability. The total disability burden of TB is likely undervalued by both GBD estimates and economic evaluations of interventions, particularly those aimed at early diagnosis and prevention.